Product Details
Ofev 150mg (Nintedanib) Capsule In Pakistan
Ofev 150mg Capsule contains nintedanib, an antifibrotic medicine used in adults with certain chronic fibrosing lung diseases. It is indicated for idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and systemic sclerosis-associated ILD. Nintedanib works by inhibiting several tyrosine kinases involved in pathways that contribute to fibrotic processes.
Ofev 150mg is supplied as a soft capsule containing 150mg of nintedanib. Treatment should be initiated and monitored by a physician experienced in managing the relevant lung condition.
Benefits
- Contains nintedanib 150mg.
- Used for approved forms of progressive fibrosing lung disease.
- Helps slow the decline of pulmonary function in appropriate patients.
- Used in adults with idiopathic pulmonary fibrosis.
- Used for chronic fibrosing ILDs with a progressive phenotype.
- Used to slow pulmonary-function decline associated with systemic sclerosis-associated ILD.
- Oral capsule formulation for convenient administration.
- Can be incorporated into a specialist-supervised long-term treatment plan.
Specifications
| Specification | Details |
|---|---|
| Brand | Ofev |
| Active Ingredient | Nintedanib |
| Strength | 150mg |
| Dosage Form | Soft Capsule |
| Route | Oral |
| Drug Class | Tyrosine Kinase Inhibitor / Antifibrotic |
| Main Indications | IPF, progressive fibrosing ILD, SSc-ILD |
| Capsule Appearance | Brown, opaque, oblong soft capsule |
| Manufacturer | Boehringer Ingelheim |
| Prescription Status | Prescription Medicine |
The 150mg capsule contains 150mg nintedanib (as nintedanib esilate).
How To Use
Take Ofev exactly as prescribed by your doctor. The usual adult dose is 150mg twice daily, approximately 12 hours apart, and it should be taken with food. Swallow the capsule whole with water; do not chew, crush, or open it.
If you miss a dose, take the next dose at its scheduled time. Do not take an extra dose to make up for the missed dose. The recommended maximum daily dose is 300mg.
Your doctor may reduce the dose to 100mg twice daily, temporarily interrupt treatment, or discontinue treatment if significant side effects occur. Liver function should be assessed before treatment and monitored during therapy.
Why Choose Ofev 150mg?
Ofev is an established antifibrotic treatment containing nintedanib for adults with specific progressive fibrosing lung diseases. Its targeted mechanism acts on tyrosine-kinase pathways involved in fibrosis, making it an important treatment option for appropriately diagnosed patients.
The 150mg twice-daily regimen is the standard recommended adult dose for patients who tolerate this strength, while dose modification can be considered when medically necessary.
